We are live on ! Find out more
LLY icon

Eli Lilly

1,005 hedge funds and large institutions have $42.1B invested in Eli Lilly in 2013 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 341 increasing their positions, 406 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 69

11% more call options, than puts

Call options by funds: $460M | Put options by funds: $416M

3% more funds holding

Funds holding: 9741,005 (+31)

2% more capital invested

Capital invested by funds: $41.1B → $42.1B (+$950M)

0.62% more ownership

Funds ownership: 72.69%73.31% (+0.62%)

16% less repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 406

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

Holders
1,005
Holders Change
+31
Holders Change %
+3.18%
% of All Funds
29.16%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.55%
New
112
Increased
341
Reduced
406
Closed
69
Calls
$460M
Puts
$416M
Net Calls
+$44.3M
Net Calls Change
-$109M
Name Holding Trade Value Shares
Change
Change in
Stake
URS
251
Utah Retirement Systems
Utah
$9.01M
MA
252
MUFG Americas
New York
$8.99M -$687K -13,719 -7%
FFIC
253
First Fiduciary Investment Counsel
Ohio
$8.77M +$8.61M +171,890 New
DILH
254
Dai-ichi Life Holdings
Japan
$8.74M -$153K -3,051 -2%
State of Tennessee, Department of Treasury
255
State of Tennessee, Department of Treasury
Tennessee
$8.71M -$32.3M -645,938 -79%
WT
256
Wilmington Trust
Delaware
$8.57M +$143K +2,853 +2%
SF
257
Synovus Financial
Georgia
$8.43M -$1.25M -24,871 -13%
WF
258
Welch & Forbes
Massachusetts
$8.4M +$249K +4,972 +3%
MSA
259
Mason Street Advisors
Wisconsin
$8.39M -$7.1M -141,865 -46%
Commonwealth Equity Services
260
Commonwealth Equity Services
Massachusetts
$8.35M -$160K -3,197 -2%
Luther King Capital Management (LKCM)
261
Luther King Capital Management (LKCM)
Texas
$8.34M +$118K +2,356 +1%
PI
262
Placemark Investments
Illinois
$8.11M -$5.06M -101,016 -39%
Connor, Clark & Lunn Investment Management (CC&L)
263
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$7.95M +$2.3M +46,002 +46%
WAM
264
World Asset Management
Michigan
$7.93M -$1.23M -24,581 -14%
QBFM
265
QS Batterymarch Financial Management
New York
$7.91M -$684K -13,653 -8%
Neuberger Berman Group
266
Neuberger Berman Group
New York
$7.81M +$93.9K +1,875 +1%
MPM
267
Meritage Portfolio Management
Kansas
$7.78M -$192K -3,827 -2%
HighTower Advisors
268
HighTower Advisors
Illinois
$7.73M +$3.42M +68,368 +82%
First Manhattan
269
First Manhattan
New York
$7.55M +$1.89M +37,670 +34%
CIBC World Market
270
CIBC World Market
Ontario, Canada
$7.44M -$3.88M -77,530 -35%
CIBC Asset Management
271
CIBC Asset Management
Ontario, Canada
$7.35M -$222K -4,438 -3%
GAM
272
Gotham Asset Management
New York
$7.2M +$4.73M +94,360 +202%
MME
273
Meag Munich Ergo
Germany
$7.07M +$6.8M +135,817 +5,264%
BF
274
BOK Financial
Oklahoma
$6.87M -$6.47M -129,129 -49%
DC
275
Deere & Company
Illinois
$6.7M +$175K +3,503 +3%

LLY Hedge Fund Activity: Q4 2013 in Review

1,005 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2013, worth a combined $42.1B — up 2.3% from $41.1B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LLY positions and 69 closed out — a net gain of 43 holders — while 341 added to existing stakes and 406 trimmed.

The largest buyer was Franklin Resources, adding an estimated $711M. The largest seller was Fidelity Investments, cutting an estimated $141M.

  • 1,005 institutional investors held Eli Lilly (LLY) as of Q4 2013, up from 974 in Q3 2013.
  • Funds reported $42.1B of Eli Lilly stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 112 funds opened new Eli Lilly positions in Q4 2013 and 69 closed out, a net change of +43 holders.
  • The largest Eli Lilly buyer in Q4 2013 was Franklin Resources, an estimated $711M added.
  • The largest Eli Lilly seller in Q4 2013 was Fidelity Investments, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.